According to Zhitong Finance App, Chaoju Ophthalmology (02219) announced that on July 23, 2026, Chaoju Eye Care (Hong Kong) Co., Ltd. (Chaoju Hong Kong, an indirect wholly-owned subsidiary of the Company) has further subscribed to structured deposit products with a total principal amount of 16 million US dollars provided by JPMorgan Chase Bank.

The subscription was funded by the Group's surplus cash rather than proceeds from global sales.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.